Advanced Search
Users Online: 520
Articles
Ahead of Print
Current Issue
Archives
Search
Simple Search
Advanced Search
Image Search
Medline Search
For Subscribers
Subscribe Now
Subscriber login
For Authors
Submit Article
Instructions
Reader Login
Sign Up
Subscriber Login
About
About Journal
Editorial Board
Contact Us
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
Citation statistics : Table of Contents
2020| July-December | Volume 7 | Issue 2
Online since
August 25, 2021
Archives
Previous Issue
Next Issue
Most popular articles
Most cited articles
Show all abstracts
Show selected abstracts
Export selected to
Cited
Viewed
PDF
REVIEW ARTICLES
Pishacha grahonmada
– Frontotemporal dementia with Vitamin B
12
deficiency?
Prasad Mamidi, Kshama Gupta
July-December 2020, 7(2):47-54
DOI
:10.4103/AYUHOM.AYUHOM_23_21
Description of 18 types of
bhutonmada
or
grahonmada
(psychiatric diseases caused by idiopathic factors) has been documented by
Maharshi Vagbhata
.
Pischacha grahonmada
(PG) is one among those 18 types. No works are available on PG till date. The concept of PG and its clinical application is unclear due to the scarcity of published literature on this topic. The aim of the present study is to explore the condition of PG in terms of contemporary psychiatric literature.
Ayurvedic
literature pertaining to “
Pishacha grahonmada
” has been collected from major classical
Ayurvedic
texts and their commentaries. Electronic databases have been searched to find out the relevant psychiatric and/or neuropsychiatric conditions which are similar to PG by using relevant keywords. PG is characterized by clinical features like
Aswastha chittam
(feeling uneasy),
naikatra tishtantam
(unable to sit at one place),
paridhaavinam
(wandering/pacing/running),
dayita nritya geeta haasa ucchishta ratim
(hypomania or mania like features),
madya maamsa ratim
(fond of eating meat, alcohol abuse),
shunya nivaasa ratim
(staying alone/social withdrawal),
nirbhartsanaat
(threatening others),
deena shankita vadanam
(depression with suspiciousness),
nakhai aatma vapushi likhantam
(self-injurious behavior with nails),
nashta smriti
(memory loss),
baddhaabaddha bhaashinam
(irrelevant speech),
akasmaat rudantam
(crying suddenly),
dukhaani aavedayamaana
(sharing his sorrows to everyone)/
dukhaani avedayamaana
(unable to feel pain),
uddhvasta
(nakedness),
rooksha deha and swara
(rough emaciated body and voice), durgandham/ashuchi (unhygienic),
rathya chaila trina aabharanam
(gross abnormal behavior), and
bahvaashinam
(hyperphagia). “
Nashta smriti
” is the unique symptom of PG and it denotes memory impairment commonly seen in conditions like dementia. The clinical features of PG have shown similarity with “Frontotemporal dementia” associated with malnutrition and/or Vitamin B
12
deficiency. The present study provides inputs for future research works.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
2
3,454
226
EDITORIAL
Initiatives taken by North Eastern institute of ayurveda and homeopathy for combating COVID-19 pandemic
PK Goswami
July-December 2020, 7(2):39-40
DOI
:10.4103/AYUHOM.AYUHOM_41_21
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
-
2,999
302
ORIGINAL ARTICLE
A study to evaluate ayurveda product labels for their compliance as per drug and cosmetic rules 1945, rule 161(B)
Raghavendra Naik, MN Shubhashree, Chandini Chandrasekharan, Sulochana Bhat
July-December 2020, 7(2):75-79
DOI
:10.4103/AYUHOM.AYUHOM_21_21
Background:
Product labels are considered as clinical instruction manual which plays a vital role in providing information to the prescriber and end-user at a glance. As Ayurvedic drugs fall under the purview of the Drugs and Cosmetics Act, 1940, a set of quality criteria-based information is required to be displayed on the labels of Ayurvedic product containers marketed in India.
Aim and Objective:
In the present study, containers of different Ayurvedic products dispensed at Government hospitals and sold at private pharmacies in Bangalore were selected and checked for their compliance with labeling guidelines as mentioned in Drugs and Cosmetic Act 1940.
Results:
Among 150 selected products, 78 products were classical preparations and 72 were proprietary medicines. Among the fourteen criteria derived from labeling guidelines mentioned in drugs and cosmetic act, all the 150 products were following the standard guidelines with respect to the six basic criteria like name and address of the manufacture, net weight of the formulation, batch number, license number, date of manufacture and mentioning of the word Ayurvedic medicine.
Conclusion:
Even though majority of the labels of Ayurvedic drug containers fulfilled the requirements, a good number of Ayurvedic products are still not in accordance with the regulatory requirements in providing label information. Following a strict compliance in some labeling specifications like providing complete details of ingredient with their net weight in metric system, displaying the caution warning for formulations containing schedule E 1 drugs, providing the expiry date, and citing the reference from authentic texts in case of classical formulations is still lacking.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
-
3,368
164
RESEARCH ARTICLE
A study on the scope of homoeopathy in the management of suicidal ideation in depressive episodes
Thounaojam Nanao, UK Girish Navada
July-December 2020, 7(2):80-85
DOI
:10.4103/AYUHOM.AYUHOM_13_21
Background:
Suicidal ideation in depressive patient is one of the risk factors for premature death due to their hopelessness, worthlessness, to escape or solve the problem, or to take revenge.
Objective:
The objective of the study is to study the effectiveness of homeopathic medicine in the management of suicidal ideation in depressive episodes.
Materials and Methods:
Thirty patients were selected for this study based on purposive sampling. The diagnosis was made on international classification of diseases-10 and DSM-V criteria, and grading of severity of depressive episodes and suicidal ideations were assessed before and after treatment by Hamilton depression rating scale and scale of suicidal ideation. This study was carried out for a period of 24 months. The remedy selection was based on the individualization of each case. Potencies ranging 30-10 M were used on the demand of the cases. Patients were reviewed on weekly basis initially and fortnightly on considerable improvement or on demand of the case. Each case was followed up for a minimum period of 6 months. The descriptive statistics such as mean, standard deviation, and percentage were used, and statistical inference was obtained by paired
t
-test with the scores of before and after treatment
P
< 0.05 was taken as significant.
Results:
Scores before and after treatment were compared and statistically significant was observed as
P
= 0.00001 which is significant. No report of suicidal behavior or attempt or no increased suicidal ideation was reported during the course of study.
Conclusion:
Homeopathic medicine is found effective in the management of suicidal ideation in depressive episodes.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
-
2,531
165
REVIEW ARTICLES
Effect of
Vaya
(Age) and its association with Panchakarma: A review
Jatinder Verma, Gopesh Mangal, Gunjan Garg
July-December 2020, 7(2):41-46
DOI
:10.4103/AYUHOM.AYUHOM_2_21
Vaya
(age) plays a significant role in Ayurveda in respect to disease, prognosis, and treatment. Three broad classifications of
Vaya
according to Ayurveda are
Balya Avastha
(young age),
Madhyama Avastha
(middle age), and
Jirna Avastha
(old age). In Ayurveda, both
Shodhana
(purification) and
Shamana
(palliative)
Chikitsa
(treatment) are indicated in various diseases according to
Vaya
. An Ayurvedic physician should follow the general rules regarding
Panchakarma
procedures after the assessment of age. The present article elaborates various
Panchakarma
procedures according to
Vaya
in respect of
Snehana
,
Swedana
,
Vamana
,
Virechana
,
Basti, Nasya,
and
Raktmokshana.
Along with the doses of drugs, instrumentation used in
Panchakarma
according to
Vaya
is also given special consideration in this article. Ayurveda texts have been studied to collect and compile data regarding the dose of drugs and instrumentation used in various
Panchakarma
procedures mentioned in relation to
Vaya
. In Ayurveda,
Vaya
is an important factor to consider particularly in the case of
Panchakarma
procedures. Special attention should be given while prescribing
Panchakarma
procedures to children and in old age.
Vaya
should be considered as an important parameter where
Shodhana
and
Shamana Chikitsa
are to be prescribed. There is a need to pay much attention to
Vaya
where
Panchakarma
procedures have to be selected, particularly in the case of children and the elderly.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
-
3,377
286
Shook Dosha
(Complication of Recipes use for Penile Enlargement) in Ayurveda: A critical review
Jitendra Nathabhai Varsakiya, Mahesh Kumar
July-December 2020, 7(2):55-61
DOI
:10.4103/AYUHOM.AYUHOM_6_21
The remedies used for the enlargement of penis are existing since ancient. The different forms of related complications are seen in their application. It has been noticed in Ayurveda texts systematically by the name of
Shook Dosha
along with their management. These groups of diseases are existing in different forms and more or less nearer to modern disorders of penis. The described subject of
Shook Dosha
is ignored and still untouched in Ayurveda fraternity. On probing the accessible sources, the systematic work on subject is not perceived. We aimed to review the
Shook Dosha
(disease or complications produced by remedies used for penile enlargement) in Ayurveda. The
Shook Doshas
of ancient classics are nothing but simply the diseases, produced by remedies used for enlargement of penis.
Shook Dosha
is produced by the person who tries to increase the size of penis with improper method (local application) which leads to eighteen types of Shookjanya (local application prepared with poisonous drugs or insects) diseases.On reviewing from sources and Ayurveda classics, the systematic description of
Shook Dosha
disease and its management is available. Currently, these
Shook Doshas
can be correlated with complications produced from the remedies used for penile enlargement. The subject has a future prospective to generate scientific data for stalwarts of Ayurveda.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
-
3,951
215
An ayurvedic approach to diagnosis and management of psoriatic arthritis on principles of
Vatarakta
: A review
Yogesh Kumar Pandey, Mansi Grewal
July-December 2020, 7(2):62-68
DOI
:10.4103/AYUHOM.AYUHOM_25_21
Psoriatic arthritis (PsA) is inflammatory arthritis usually occurring in patients with psoriasis. Even though skin disease and joint involvement are linked in PsA, they can occur irrespective of each other. An equivalent entity in
Ayurvedic
literature,
Vatarakta
is a disabling illness occurring due to the concurrent aggravation of
Vata
and
Rakta
. Its
Moolasthana (~
primary site) of manifestation is joints of hands and feet. With this article, we aim to develop a clinical approach to PsA on the principles of
Vatarakta.
Relevant information from authentic texts of
Ayurveda
and contemporary medical literature is gathered, and facts are analyzed to find similarities and dissimilarities between PsA and
Vatarakta's
etiology, pathogenesis, clinical features, prognosis, and management principles. It was seen that PsA bears similarity to
Vatarakta
on grounds of etiology, pathogenesis, and clinical features. The few differences seen are not found to be conceptually contradictory. Concepts of
Vatarakta
can explain the vascular, dermal, musculoskeletal, and systemic changes seen in PsA. The differential of
Asthimajjagata Kushtha, Kushtha Updrava,
and
Aamvata
is mandatory to rule out any diagnostic dilemma. Often the patients with psoriasis and/or PsA have hyperuricemia, which has been long viewed and treated on principles of
Vatarakta.
Hence,
Vatarakta
may be seen as an umbrella term for immune-mediated or inflammatory musculoskeletal disorders with dermal and systemic manifestations. Clinically, PsA can be understood and managed on principles of
Vatarakta
.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
-
3,007
189
COVID-19: A new horizon for ayurveda
Bishnu Choudhury, PK Goswami
July-December 2020, 7(2):69-74
DOI
:10.4103/AYUHOM.AYUHOM_38_21
Novel coronavirus disease (COVID-19), which was first noticed in Wuhan city of China in mid-December, 2019, has stormed health-care system along with the economy across globally. After hitting India in its 2
nd
wave causing devasting to human lives is about to hit again in its 3
rd
wave reports suggests. Even after putting every effort by the health-care workers, research scientists, microbiologists, and interdisciplinary authorities could not develop a gold standard strategy to contain COVID-19.
Ayurveda
documented epidemics/pandemics under the context of
Janapadodhvamsa
(conditions devastate the human settlements). Similarly, infectious diseases have been considered under
Sankramika rogas
. Pollution of air, water, climate, and environment is responsible for the spread of diseases on such a large scale, resulting in
Janapadodhvamsa
. Causes of vitiation of air, water, climate, and place along with their characteristics have been enumerated in ancient
Ayurvedic
classics which result in reasonable damage to the health of the society, ultimately leading to
Janapadodhwamsa
. Such conditions will manifest in symptoms such as cough, breathlessness, and fever. In
Ayurveda
, the initial phases of the manifestation can be comparable to
Vata-Kaphaja Jwara
. Uncontrolled conditions, further vitiate other
Doshas
and other
Rasa, Rakta,
and
Mamsadi dushyas,
thus entering into
Sannipataja
condition. Lots of drugs in
Ayurveda
are on the threshold of being identified as a potential treatment in COVID-19 which will be analyzed in this review article and along with other strategies to combat the COVID-19 pandemic though
Ayurveda
.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
-
2,993
238
© AYUHOM | Published by Wolters Kluwer -
Medknow
Sitemap
|
What's New
|
Feedback
|
Disclaimer
|
Privacy Notice
Online since 31
st
December 2020